Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


Affiliata alla Society of Radiopharmaceutical Sciences e all'International Research Group of Immunoscintigraphy
Pubblicazione segnalata su: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 1,931


Periodicità: Trimestrale

pISSN 1824-4785

eISSN 1827-1936

Gli articoli più letti nelle ultime tre settimane

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):267-77
Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles
Shokeen M., Fettig N. M., Rossin R.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):229-34
Radioiodine therapy of advanced differentiated thyroid cancer: clinical considerations and multidisciplinary approach
Luca GIOVANELLA *, Lorenzo SCAPPATICCIO

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):278-83
The effects of androgen deprivation therapy on fluoromethylcholine uptake in prostate cancer patients undergoing neoadjuvant treatment
Laura EVANGELISTA *, Fabio ZATTONI, Andrea GUTTILLA, Umberto BASSO, Filiberto ZATTONI

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):136-49
Molecular imaging of bone metastases using tumor-targeted tracers
Najme KARAMZADE-ZIARATI, Reyhaneh MANAFI-FARID, Bahar ATAEINIA, Werner LANGSTEGER, Christian PIRICH, Felix M. MOTTAGHY, Mohsen BEHESHTI *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):112-28
Molecular imaging of bone metastases using bone targeted tracers
Sofia VAZ *, Sharjeel USMANI, Gopinath GNANASEGARAN, Tim Van den WYNGAERT

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):235-52
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer
Manuel WEBER, Ina BINSE, James NAGARAJAH, Andreas BOCKISCH, Ken HERRMANN, Walter JENTZEN *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):227-8
Radioiodine dosimetry in advanced thyroid cancer
Luca GIOVANELLA *, Michael LASSMANN

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):355-70
CT radiomics and PET radiomics: ready for clinical implementation?
Marta BOGOWICZ *, Diem VUONG, Martin W. HUELLNER, Matea PAVIC, Nicolaus ANDRATSCHKE, Hubert S. GABRYS, Matthias GUCKENBERGER, Stephanie TANADINI-LANG

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):321-2
Radiomics in nuclear medicine and hybrid imaging: current standings on clinical applicability
Patrick VEIT-HAIBACH *, Issam EL NAQA, Dimitris VISVIKIS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):347-54
Are radiomics ready for clinical prime-time in PET/CT imaging?
Catherine CHEZE LE REST *, Roland HUSTINX

inizio pagina